PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:36 AM ET

Sponsor Check › Person

RE
No photo found yet (own website and image search run after this page is viewed)

Robert Essner

Named as an officer, director or promoter on SEC Form D filings · NJ, NY, PA · Jul 30, 2012 → Aug 3, 2023

2deals (issuers)
$234.9Mreported sold
357investors
16Form D filings
2012–2023years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:18 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Robert Essner is listed as an executive officer and director on 16 SEC Form D filings by 2 issuers between Jul 2012 and Aug 2023: AMICUS THERAPEUTICS, INC. (Princeton, NJ — biotechnology — 2012–2021; $199.9M reported sold to 29 investors) and Elucida Oncology, Inc. (Monmouth Junction, NJ — biotechnology — 2019–2023; $35M reported sold to 328 investors).

What this means 2 separate companies raised money with this person listed as executive officer and director, over about 11 years. Across those companies the filings report $234.9M sold in total.

Listed alongside Geno Germano (11 shared filings), Tim Boris (11 shared filings), Ulrich Wiesner (11 shared filings), Robert Ruffolo (9 shared filings), Teresa Ressel (8 shared filings) and 42 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Robert. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 bankruptcy case matching the name listed in Key records below.

What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 16 public filings for Robert Essner and found 19 differences, 2 worth asking the sponsor about: Amount sold went down between filings; Investor count went down between filings; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Robert Essner has not run yet — it is joining a line of 19,179 names; searches run around the clock at the hosts' allowed rate. Searched so far: 31 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:18 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Robert Essner..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

1 case: 1 closed (disposition not in docket feed)

ROBERT A ESSNER and VICTORIA L ESSNER closed
United States Bankruptcy Court, D. Nevada · No. 04-17866 · Filed Jul 20, 2004 · Closed Dec 10, 2004
Role of ROBERT A ESSNER and VICTORIA L ESSNER: Debtor · Outcome: Case closed 2004-12-10 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (rare in federal dockets); 4 people with this name in Form D filings; court in NV (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:18 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

19 differences found between the filings for Robert Essner — 2 worth asking about (compared 16 filings on Oct 24, 2026)

Worth asking · Jun 15, 2023 – Aug 3, 2023

Amount sold went down between filings — Elucida Oncology, Inc.

The Jun 15, 2023 filing says $22,936,960 sold; the Aug 3, 2023 Form D/A says $22,284,600 sold — $652,360 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Form D (earlier) · Jun 15, 2023 ↗Form D/A (later) · Aug 3, 2023 ↗Elucida Oncology, Inc. — PartnerFacts page ↗
Sources
Worth asking · Jun 15, 2023 – Aug 3, 2023

Investor count went down between filings — Elucida Oncology, Inc.

The Jun 15, 2023 filing reports 277 investors; the Aug 3, 2023 Form D/A reports 107 investors.

What this means Investor counts normally only grow. A smaller number can mean investors left or were refunded, or a count was corrected. Ask the sponsor what happened.

Form D (earlier) · Jun 15, 2023 ↗Form D/A (later) · Aug 3, 2023 ↗Elucida Oncology, Inc. — PartnerFacts page ↗
Sources
Note · May 24, 2023 – Jun 15, 2023

Form D filed 22 days after the first sale — Elucida Oncology, Inc.

The filing says the first sale was May 24, 2023. The Form D was filed Jun 15, 2023 — 22 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 7 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Jun 15, 2023 ↗Elucida Oncology, Inc. — PartnerFacts page ↗
Sources
Note · Mar 11, 2022 – Mar 28, 2022

Form D filed 17 days after the first sale — Elucida Oncology, Inc.

The filing says the first sale was Mar 11, 2022. The Form D was filed Mar 28, 2022 — 17 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 2 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Mar 28, 2022 ↗Elucida Oncology, Inc. — PartnerFacts page ↗
Sources
Note · Jun 15, 2023 – Aug 3, 2023

Robert Essner's role changed at Elucida Oncology, Inc.: director → executive officer, director

The Jun 15, 2023 filing lists Robert Essner as director; the Aug 3, 2023 Form D/A lists executive officer, director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Jun 15, 2023 ↗Form D/A · Aug 3, 2023 ↗Robert Essner — PartnerFacts page ↗Elucida Oncology, Inc. — PartnerFacts page ↗
Sources
Note · Mar 28, 2022 – Jun 15, 2023

Robert Essner's role changed at Elucida Oncology, Inc.: executive officer, director → director

The Mar 28, 2022 filing lists Robert Essner as executive officer, director; the Jun 15, 2023 Form D lists director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Mar 28, 2022 ↗Form D · Jun 15, 2023 ↗Robert Essner — PartnerFacts page ↗Elucida Oncology, Inc. — PartnerFacts page ↗
Sources
Note · Feb 7, 2019 – May 26, 2020

Robert Essner's role changed at Elucida Oncology, Inc.: director → executive officer, director

The Feb 7, 2019 filing lists Robert Essner as director; the May 26, 2020 Form D lists executive officer, director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D/A · Feb 7, 2019 ↗Form D · May 26, 2020 ↗Robert Essner — PartnerFacts page ↗Elucida Oncology, Inc. — PartnerFacts page ↗
Sources
Note · Jun 15, 2023 – Aug 3, 2023

Offering amount lowered between filings — Elucida Oncology, Inc.

The Jun 15, 2023 filing says $40,000,000 offered; the Aug 3, 2023 Form D/A says $22,284,600.

What this means The target raise got smaller. That can mean the plan shrank or the sponsor stopped early. Ask what changed in the deal.

Form D (earlier) · Jun 15, 2023 ↗Form D/A (later) · Aug 3, 2023 ↗Elucida Oncology, Inc. — PartnerFacts page ↗
Sources
Note · May 13, 2020 – Jun 4, 2020

No amendment in the last 12 months on an offering that may still be open — Elucida Oncology, Inc. (latest filing Jun 4, 2020)

The latest filing for this offering is dated Jun 4, 2020 (first sale May 13, 2020). It reports $8,782,683 sold of $30,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D/A · Jun 4, 2020 ↗Elucida Oncology, Inc. — PartnerFacts page ↗
Sources
Note · Aug 15, 2017 – Feb 7, 2019

No amendment in the last 12 months on an offering that may still be open — Elucida Oncology, Inc. (latest filing Feb 7, 2019)

The latest filing for this offering is dated Feb 7, 2019 (first sale Aug 15, 2017). It reports $28,759,605 sold of $30,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D/A · Feb 7, 2019 ↗Elucida Oncology, Inc. — PartnerFacts page ↗
Sources
Note · Jul 30, 2012 – Jan 3, 2019

Robert Essner is written 2 different ways on the filings

listed as "Robert Essner" on 14 filings (from Jul 30, 2012), and "Robert A. Essner" on 2 filings (from Jan 3, 2019).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Jul 30, 2012 ↗Form D/A · Jan 3, 2019 ↗Robert Essner — PartnerFacts page ↗
Sources
Note · May 10, 2019 – Sep 14, 2023

Same name, different state: "Robert Essner" (FL) is a separate record

This page covers filings where the address state is NJ or NY or PA. A separate record, "Robert Essner" with address state FL, is listed on 5 filings — most recently by Omeza Holdings, Inc. (Sep 14, 2023). Both records have filings in the same period (May 10, 2019 to Aug 3, 2023).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Robert Essner (FL) — PartnerFacts page ↗Form D · Sep 14, 2023 ↗Omeza Holdings, Inc. — PartnerFacts page ↗Robert Essner (NJ,NY,PA) — this page ↗
Sources
Note · Jun 21, 2012

Same name, different state: "Robert Essner" (NC) is a separate record

This page covers filings where the address state is NJ or NY or PA. A separate record, "Robert Essner" with address state NC, is listed on 1 filing — most recently by Jaguar Holding Co I (Jun 21, 2012). The two records do not overlap in time: this page runs Jul 30, 2012 to Aug 3, 2023; the other has one filing dated Jun 21, 2012.

What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.

Robert Essner (NC) — PartnerFacts page ↗Form D · Jun 21, 2012 ↗Jaguar Holding Co I — PartnerFacts page ↗Robert Essner (NJ,NY,PA) — this page ↗
Sources
Note · Apr 15, 2009 – Apr 16, 2010

Same name, different state: "Robert A Essner" (NJ or MA or FL) is a separate record

This page covers filings where the address state is NJ or NY or PA. A separate record, "Robert A Essner" with address state NJ or MA or FL, is listed on 10 filings — most recently by Massachusetts Mutual Variable Life Separate Account III (Jun 7, 2012). The two records do not overlap in time: this page runs Jul 30, 2012 to Aug 3, 2023; the other runs Apr 15, 2009 to Apr 16, 2010.

What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.

Robert A Essner (NJ,MA,FL) — PartnerFacts page ↗Form D/A · Jun 7, 2012 ↗Massachusetts Mutual Variable Life Separate Account III — PartnerFacts page ↗Robert Essner (NJ,NY,PA) — this page ↗
Sources
Note · Jul 19, 2016 – Oct 13, 2021

Address moved from Cranbury, NJ to Philadelphia, PA — AMICUS THERAPEUTICS, INC.

The people listed on the Jul 19, 2016 filing give Cranbury, NJ; on the Oct 13, 2021 filing they give Philadelphia, PA. The address now on file (47 Hulfish Street, Princeton, NJ) is a registered-agent or shared-office address used by 18 issuers.

What this means A registered agent's address is a mailbox, not where the team works. Ask where the business actually operates.

Form D · Jul 19, 2016 ↗Form D · Oct 13, 2021 ↗AMICUS THERAPEUTICS, INC. — PartnerFacts page ↗
Sources
Note · Feb 7, 2019 – May 26, 2020

Address moved from New York, NY to Monmouth Junction, NJ — Elucida Oncology, Inc.

The people listed on the Feb 7, 2019 filing give New York, NY; on the May 26, 2020 filing they give Monmouth Junction, NJ.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D/A · Feb 7, 2019 ↗Form D · May 26, 2020 ↗Elucida Oncology, Inc. — PartnerFacts page ↗
Sources
Note · Jul 30, 2012 – Aug 3, 2023

Robert Essner is listed with 3 different address states: NJ, NY, PA

NJ on 13 filings (Jul 30, 2012 to Aug 3, 2023); NY on 2 filings (Jan 3, 2019 to Feb 7, 2019); PA on 1 filing (Oct 13, 2021).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Jul 30, 2012 ↗Form D/A · Jan 3, 2019 ↗Form D · Oct 13, 2021 ↗
Sources
Note · Jul 30, 2012 – Oct 13, 2021

Reported revenue range changed between filings — AMICUS THERAPEUTICS, INC.

"$5,000,001 - $25,000,000" (Jul 30, 2012); then "$1,000,001 - $5,000,000" (Dec 3, 2013); then "Decline to Disclose" (Jul 19, 2016); then "Over $100,000,000" (Oct 13, 2021).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Jul 30, 2012 ↗Form D · Dec 3, 2013 ↗Form D · Jul 19, 2016 ↗Form D · Oct 13, 2021 ↗
Sources
Note · Aug 22, 2017 – May 26, 2020

Reported revenue range changed between filings — Elucida Oncology, Inc.

"Decline to Disclose" (Aug 22, 2017); then "No Revenues" (May 26, 2020).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Aug 22, 2017 ↗Form D · May 26, 2020 ↗Elucida Oncology, Inc. — PartnerFacts page ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

6 of 10 offerings report sales commissions totalling $11,611,952; 1 reports finder's fees totalling $5,000; 1 reports proceeds to related persons totalling $400,000. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Aug 3, 2023 D/A
Elucida Oncology, Inc.
File 021-484316
$2,228,460$0$0Maxim Group LLC BrokerCheck CRD 120708 ↗EDGAR ↗
Mar 28, 2022 D
Elucida Oncology, Inc.
File 021-439279
$2,228,460$0$0Maxim Group LLC BrokerCheck CRD 12078 ↗EDGAR ↗
Oct 13, 2021 D
AMICUS THERAPEUTICS, INC.
File 021-416812
$0$0$0None listed on this filingEDGAR ↗
Jan 12, 2021 D/A
Elucida Oncology, Inc.
File 021-380142
$3,500,000$0$0Maxim Group LLC BrokerCheck CRD 12078 ↗EDGAR ↗
Jun 4, 2020 D/A
Elucida Oncology, Inc.
File 021-367640
$774,072$0$0Maxim Group LLC BrokerCheck CRD 12078 ↗EDGAR ↗
Feb 7, 2019 D/A
Elucida Oncology, Inc.
File 021-293250
$2,875,960 (est.)$0$400,000
Upon a closing of $15 million in the aggregate, Mr. Edward Rosen, the Company's former CEO, is entitled to the receive up to $400,000 relating to various consulting fees and the reimbursement of expenses pursuant to the terms of his employment agreement.
Maxim Group LLC BrokerCheck CRD 12078 ↗EDGAR ↗
Jul 19, 2016 D
AMICUS THERAPEUTICS, INC.
File 021-267307
$5,000$5,000$0None listed on this filingEDGAR ↗
Dec 3, 2013 D
AMICUS THERAPEUTICS, INC.
File 021-207312
$0$0$0None listed on this filingEDGAR ↗
Dec 3, 2013 D
AMICUS THERAPEUTICS, INC.
File 021-207313
$0$0$0None listed on this filingEDGAR ↗
Jul 30, 2012 D
AMICUS THERAPEUTICS, INC.
File 021-181955
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 2

Every issuer that named Robert Essner on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

EO
Biotechnology

Elucida Oncology, Inc.

Monmouth Junction, NJ · Jan 3, 2019 → Aug 3, 2023 · 11 filings
  • Aug 3, 2023 · D/A · $22,284,600 sold of $22,284,600 · 107 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jun 15, 2023 · D · $22,936,960 sold of $40,000,000 · 277 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 28, 2022 · D · $22,284,600 sold of $22,284,600 · 107 investors · min. $100,000 · role: Executive Officer, Director EDGAR ↗
  • Jan 12, 2021 · D/A · $35,000,000 sold of $35,000,000 · 328 investors · min. $12,500 · role: Executive Officer, Director EDGAR ↗
  • Dec 29, 2020 · D/A · $32,552,878 sold of $35,000,000 · 303 investors · min. $12,500 · role: Executive Officer, Director EDGAR ↗
  • Dec 10, 2020 · D/A · $27,236,639 sold of $35,000,000 · 149 investors · min. $12,500 · role: Executive Officer, Director EDGAR ↗
  • Nov 10, 2020 · D · $17,693,118 sold of $35,000,000 · 149 investors · min. $12,500 · role: Executive Officer, Director EDGAR ↗
  • Jun 4, 2020 · D/A · $8,782,683 sold of $30,000,000 · 126 investors · min. $11,400 · role: Executive Officer, Director EDGAR ↗
  • May 26, 2020 · D · $7,389,785 sold of $30,000,000 · 104 investors · min. $11,400 · role: Executive Officer, Director EDGAR ↗
  • Feb 7, 2019 · D/A · $28,759,605 sold of $30,000,000 · 175 investors · min. $25,000 · role: Director EDGAR ↗
  • Jan 3, 2019 · D/A · $28,094,604 sold of $30,000,000 · 170 investors · min. $25,000 · role: Director EDGAR ↗

Raised $35M from 328 investors (100% of the $22.3M target) as of the latest filing. Robert is listed as executive officer, director on 11 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AT
Biotechnology

AMICUS THERAPEUTICS, INC.

Princeton, NJ · Jul 30, 2012 → Oct 13, 2021 · 5 filings
  • Oct 13, 2021 · D · $199,916,500 sold of $199,916,500 · 9 investors · min. $2,149,996 · role: Director EDGAR ↗
  • Jul 19, 2016 · D · $4,706,000 sold of $4,706,000 · 18 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 3, 2013 · D · $15,000,000 sold of $15,000,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 3, 2013 · D · $15,000,000 sold of $15,000,000 · 29 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 30, 2012 · D · $18,582,360 sold of $18,582,360 · 1 investors · min. $18,582,360 · role: Director EDGAR ↗

Raised $199.9M from 29 investors (100% of the $199.9M target) as of the latest filing. Robert is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other pages with the same name (3)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Robert A Essner — NJ, MA, FL, 2 issuers, Apr 15, 2009 → Apr 16, 2010 · no shared issuer
  • Robert Essner — FL, 2 issuers, May 10, 2019 → Sep 14, 2023 · no shared issuer
  • Robert Essner — NC, 1 issuer, Jun 21, 2012 → Jun 21, 2012 · no shared issuer

People around Robert 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

UW
No photo found yet (own website and image search run after this page is viewed)
Person

Ulrich Wiesner

Director · 11 shared filings (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

GG
No photo found yet (own website and image search run after this page is viewed)
Person

Geno Germano

Executive Officer, Director · 11 shared filings (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

TB
No photo found yet (own website and image search run after this page is viewed)
Person

Tim Boris

Director · 11 shared filings (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

RR
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Ruffolo

Director · 9 shared filings (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

TR
No photo found yet (own website and image search run after this page is viewed)
Person

Teresa Ressel

Director · 8 shared filings (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

MS
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Smith

Director · 6 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Robert Essner. Their page shows their other deals.

GA
No photo found yet (own website and image search run after this page is viewed)
Person

Gregory Adams

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

MM
No photo found yet (own website and image search run after this page is viewed)
Person

Margaret G. McGlynn

Director · 5 shared filings (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

MR
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Raab

Director · 5 shared filings (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

JC
No photo found yet (own website and image search run after this page is viewed)
Person

John F. Crowley

Executive Officer, Director · 5 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Robert Essner. Their page shows their other deals.

DQ
No photo found yet (own website and image search run after this page is viewed)
Person

Daphne Quimi

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

EB
No photo found yet (own website and image search run after this page is viewed)
Person

Eliel Bayever

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

KM
No photo found yet (own website and image search run after this page is viewed)
Person

Kai Ma

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

WB
No photo found yet (own website and image search run after this page is viewed)
Person

William D. Baird, III

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

DH
No photo found yet (own website and image search run after this page is viewed)
Person

Donald J. Hayden, Jr.

Director · 4 shared filings (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

SB
No photo found yet (own website and image search run after this page is viewed)
Person

Sol J Barer

Director · 4 shared filings (1 issuer) · also on 8 other issuers

Sol J Barer is on 9 issuers in total — a repeat sponsor. Their page lists every one.

GS
No photo found yet (own website and image search run after this page is viewed)
Person

Glenn Sblendorio

Director · 4 shared filings (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

BC
No photo found yet (own website and image search run after this page is viewed)
Person

Bradley L. Campbell

Executive Officer, Director · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Robert Essner. Their page shows their other deals.

TL
No photo found yet (own website and image search run after this page is viewed)
Person

Ted W. Love

Director · 4 shared filings (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

DL
No photo found yet (own website and image search run after this page is viewed)
Person

David Lockhart

Executive Officer · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Robert Essner. Their page shows their other deals.

JT
No photo found yet (own website and image search run after this page is viewed)
Person

James N. Topper

Director · 3 shared filings (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

JK
No photo found yet (own website and image search run after this page is viewed)
Person

John R. Kirk

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

James Barrett

Director · 3 shared filings (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

KV
No photo found yet (own website and image search run after this page is viewed)
Person

Ken Valenzano

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

ED
No photo found yet (own website and image search run after this page is viewed)
Person

Enrique Dilone

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

KP
No photo found yet (own website and image search run after this page is viewed)
Person

Kenneth W. Peist

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

GS
No photo found yet (own website and image search run after this page is viewed)
Person

Gary Sender

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Robert Essner. Their page shows their other deals.

DZ
No photo found yet (own website and image search run after this page is viewed)
Person

David Zacardelli

Director · 3 shared filings (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

NM
No photo found yet (own website and image search run after this page is viewed)
Person

Natalie MacDonald

Director · 3 shared filings (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

IB
No photo found yet (own website and image search run after this page is viewed)
Person

Isaac Blech

Director · 2 shared filings (1 issuer) · also on 19 other issuers

Isaac Blech is on 20 issuers in total — a repeat sponsor. Their page lists every one.

JW
No photo found yet (own website and image search run after this page is viewed)
Person

Joan C. Winterbottom

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

JC
No photo found yet (own website and image search run after this page is viewed)
Person

Jeffrey P. Castelli

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

JG
No photo found yet (own website and image search run after this page is viewed)
Person

Jayne Gerskowitz

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

CW
No photo found yet (own website and image search run after this page is viewed)
Person

Craig A. Wheeler

Director · 2 shared filings (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

RR
No photo found yet (own website and image search run after this page is viewed)
Person

Robert A. Ruffolo

Director · 2 shared filings (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

MS
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Thomas Smith

Director · 2 shared filings (1 issuer) · also on 7 other issuers

Michael Thomas Smith is on 8 issuers in total — a repeat sponsor. Their page lists every one.

PB
No photo found yet (own website and image search run after this page is viewed)
Person

Pol F. Boudes

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

RW
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Winkler

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

GS
No photo found yet (own website and image search run after this page is viewed)
Person

Glen Sblendorio

Director · 1 shared filing (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

SP
No photo found yet (own website and image search run after this page is viewed)
Person

Samantha Prout

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Robert Essner. Their page shows their other deals.

The team behind the deals

Same business address

13 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 2 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Robert Essner by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 2 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Robert Essner is listed on: none on file. No website or social profile named in Elucida Oncology, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #120,711 of 374,652 in line (48 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Monmouth Junction, NJ). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗New Jersey state courts — find the court ↗New York WebCivil Supreme ↗Pennsylvania UJS portal case search ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

New Jersey Secretary of State business search ↗New York Secretary of State business search ↗Pennsylvania Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Robert Essner appears on a new Form D, or when a court case or SEC action is matched to them. See plans →